Open an account

Hemab Therapeutics Holdings

COAG · NASDAQ

$34.17+$2.08 (+6.48%)TodayMarket closed ·
Prev close $32.09

Latest news

  • Press releasePRNewswire

    The Galien Foundation Announces 2026 Prix Galien USA Nominees for "Best Digital Health Solution," "Best Medical Technology," "Incubators, Accelerators and Equity," and "Best Startup"

  • Press releaseGlobe Newswire

    Hemab Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

  • Press releaseGlobe Newswire

    Hemab Therapeutics Presents Clinical and Preclinical Data from Sutacimig in Glanzmann Thrombasthenia and Factor VII Deficiency at the ISTH 2026 Congress

  • NewsVandana Singh

    Hemab Advances Bleeding Disorder Pipeline

  • Press releaseGlobe Newswire

    Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the ISTH 2026 Congress

  • News

    Earnings Scheduled For May 21, 2026

  • Press releaseGlobe Newswire

    Hemab Therapeutics Reports First Quarter 2026 Financial Results

  • NewsAvi Kapoor

    Norwegian Cruise Line, Aura Biosciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.